(PDF) O2-4-2a Phase II Study on the Efficacy of Nivolumab

O2-4-2a Phase II Study on the Efficacy of Nivolumab in Japanese Patients With Cancer of Unknown Primary (CUP) (NivoCUP)

Annals of Oncology - United Kingdom

doi 10.1093/annonc/mdy374.026

Full Text

Abstract

Available in full text

Categories

Date

October 1, 2018

Authors

Hidetoshi Hayashi

Hironobu Minami

Yoshihiko Segawa

Yasuhiro Kidera

Kazuhiko Nakagawa

Publisher

Elsevier BV

Related search

OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- Or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)

Journal of Thoracic Oncology

Respiratory Medicine

English

Phase II Study of Docetaxel in Patients With Metastatic Pancreatic Cancer: A Japanese Cooperative Study

British Journal of Cancer

Cancer Research

English

A Multicenter Phase I/Ii Study of Enzalutamide in Japanese Patients With Castration-Resistant Prostate Cancer

International Journal of Clinical Oncology

English

Docetaxel and Cisplatin in Patients With Advanced Gastric Cancer: Results of Japanese Phase I/Ii Study

Cancer Research

Gastroenterology

English

Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients With the Unknown Primary Site

English

Diagnostic and Health Service Pathways to Diagnosis of Cancer-Registry Notified Cancer of Unknown Primary Site (CUP)

Multidisciplinary

English

Efficacy and Safety of Vigabatrin in Japanese Patients With Infantile Spasms: Primary Short-Term Study and Extension Study

Epilepsy and Behavior

Behavioral Neuroscience

English

Long-Term Pemetrexed Administration in 22 Patients With Non-Small Cell Lung Cancer in a Japanese Phase II Randomized Study

Japanese Journal of Lung Cancer

Respiratory Medicine

English

Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer

Journal of Clinical Oncology

Cancer Research

English